BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.91B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$704M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$115M |
| 2 |
iShares US Financials ETF
IYF
|
+$109M |
| 3 |
Visa
V
|
+$108M |
| 4 |
Charter Communications
CHTR
|
+$73.8M |
| 5 |
Honeywell
HON
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.66% |
| 2 | Healthcare | 6.66% |
| 3 | Financials | 5.71% |
| 4 | Consumer Discretionary | 5.02% |
| 5 | Communication Services | 4.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Wrap Technologies
WRAP
$97.4M
| $16.1K | ﹤0.01% |
3,774
+2,424
| +180% | +$14.4K |
|
3802
Biglari Holdings Class B
BH
$1.22B
| $16K | ﹤0.01% |
312
+145
| +87% | +$14.2K |
|
|
TEUM
3803
DELISTED
Pareteum Corporation
TEUM
| $16K | ﹤0.01% |
38,771
+15,165
| +64% | +$9.04K |
|
3804
Marchex
MCHX
$80.6M
| $15.9K | ﹤0.01% |
10,985
+2,519
| +30% | +$7.25K |
|
3805
Marker Therapeutics
MRKR
$18.5M
| $15.9K | ﹤0.01% |
836
+457
| +121% | +$11.6K |
|
|
LOVE
3806
LoveSac
LOVE
$258M
| $15.8K | ﹤0.01% |
2,715
+1,469
| +118% | +$15K |
|
|
EVLO
3807
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $15.8K | ﹤0.01% |
211
+62
| +42% | +$5.9K |
|
|
BHR
3808
Braemar Hotels & Resorts
BHR
$139M
| $15.7K | ﹤0.01% |
9,254
+1,592
| +21% | +$10.5K |
|
3809
TETRA Technologies
TTI
$1.25B
| $15.7K | ﹤0.01% |
48,966
+6,023
| +14% | +$7.14K |
|
3810
UBS Group
UBS
$176B
| $15.5K | ﹤0.01% |
+1,677
| New | +$19.3K |
|
|
JAX
3811
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $15.5K | ﹤0.01% |
4,051
+926
| +30% | +$7.56K |
|
|
FLNT
3812
Fluent
FLNT
$132M
| $15.4K | ﹤0.01% |
2,193
+1,146
| +109% | +$15.7K |
|
3813
Angi Inc
ANGI
$196M
| $15.4K | ﹤0.01% |
293
-2
| -0.7% | -$149 |
|
|
ELOX
3814
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
| $15.3K | ﹤0.01% |
195
+94
| +93% | +$15.3K |
|
3815
Altisource Portfolio Solutions
ASPS
$65.6M
| $15.2K | ﹤0.01% |
248
+67
| +37% | +$8.41K |
|
3816
Schwab US REIT ETF
SCHH
$11.4B
| $15K | ﹤0.01% |
916
-4,362
| -83% | -$93.1K |
|
3817
Clear Channel Outdoor Holdings
CCO
$1.18B
| $15K | ﹤0.01% |
23,368
+2,979
| +15% | +$6.33K |
|
|
MR
3818
DELISTED
Montage Resources Corporation Common Stock
MR
| $14.9K | ﹤0.01% |
6,623
+1,484
| +29% | +$5.65K |
|
3819
Alpha Metallurgical Resources
AMR
$1.97B
| $14.9K | ﹤0.01% |
6,329
+1,123
| +22% | +$6.43K |
|
|
CBL
3820
DELISTED
CBL& Associates Properties, Inc.
CBL
| $14.9K | ﹤0.01% |
74,274
+11,068
| +18% | +$7.52K |
|
3821
Flotek Industries
FTK
$1.25B
| $14.8K | ﹤0.01% |
2,764
+629
| +29% | +$5.7K |
|
3822
Nexa Resources
NEXA
$1.9B
| $14.8K | ﹤0.01% |
4,239
| – | – |
|
|
CHA
3823
DELISTED
China Telecom Corporation, LTD
CHA
| $14.3K | ﹤0.01% |
469
-292
| -38% | -$10.9K |
|
3824
Solid Biosciences
SLDB
$974M
| $14.3K | ﹤0.01% |
399
+252
| +171% | +$12.5K |
|
|
ASRT
3825
DELISTED
Assertio
ASRT
| $14.3K | ﹤0.01% |
366
+75
| +26% | +$4.75K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2020 Portfolio in Review
As of Q1 2020, BNP Paribas Financial Markets held 4,585 positions worth $48.8B, down 11% from $54.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BNP Paribas Financial Markets deployed $12.8B of net new capital in Q1 2020, opening 132 new positions and adding to 2,502 existing holdings. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $115M trimmed.
- BNP Paribas Financial Markets's largest Q1 2020 buy was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $2.91B increase.
- BNP Paribas Financial Markets's biggest Q1 2020 reduction was Pfizer, cutting an estimated $115M.
- BNP Paribas Financial Markets fully exited State Street SPDR S&P Health Care Equipment ETF in Q1 2020, selling an estimated $47.1M.
- BNP Paribas Financial Markets's ten largest holdings make up 21% of its $48.8B portfolio in Q1 2020.
- BNP Paribas Financial Markets opened 132 new positions and closed 257 in Q1 2020.
- BNP Paribas Financial Markets's portfolio value fell 11% quarter-over-quarter to $48.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.